Ifp Advisors, Inc Arbutus Biopharma Corp Transaction History

Ifp Advisors, Inc

  • $3.28 Billion
  • Q2 2025
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025
BUY
$2.88 - $3.61 $0 - $0
0 New
0 $0
Q1 2025

May 05, 2025
BUY
$3.06 - $3.59 $0 - $0
0 New
0 $0
Q4 2024

Feb 04, 2025
BUY
$3.18 - $4.2 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
SELL
$3.41 - $4.57 $34 - $45
-10 Closed
0 $0
Q4 2017

Jan 24, 2018
SELL
$4.45 - $7.7 $1,557 - $2,695
-350 Reduced 97.22%
10 $0
Q4 2016

Jun 03, 2019
BUY
N/A
250 Added 227.27%
360 $1,000
Q2 2016

Jun 03, 2019
BUY
N/A
110
110 $0

Others Institutions Holding ABUS

# of Institutions
184
Shares Held
118M
Call Options Held
1M
Put Options Held
478K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $682M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email